Immunotherapy of viral infections with transfer factor.
It has been reported that dialysable leucocyte extract preparations, thought to contain transfer factor, may be used therapeutically for the treatment of a variety of immunodeficiency syndromes. Clinical and laboratory studies have suggested that such preparations, in addition to transferring specific cellular immunity may also contain non-specific adjuvant activities. Attempts at immunotherapy of viral infections are described against a background of current research on the biological and biochemical properties of leucocyte dialysates.
D000328:Adult; D000818:Animals; D002648:Child; D006509:Hepatitis B / Q000628:therapy; D006562:Herpes Zoster / Q000628:therapy; D006566:Herpesviridae Infections / Q000628:therapy; D006801:Humans; D006968:Hypersensitivity, Delayed; D007167:Immunotherapy; D007223:Infant; D008297:Male; D013344:Subacute Sclerosing Panencephalitis / Q000628:therapy; D014165:Transfer Factor / Q000627:therapeutic use*; D014777:Virus Diseases / Q000628:therapy*
D014165:Transfer Factor